Charleston, SC -- (SBWIRE) -- 09/23/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Skullcandy Inc (NASDAQ:SKUL), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Geron Corporation (NASDAQ:GERN).
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) opened its last trade at the price of $5.69. Its closing price was $5.60 after losing -1.58% for the day. The company traded with the total volume of 2,413,735 shares, while its average trading volume remained 903,152.00 shares. The beta of this stock stands at 0.66. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France.
Has IDIX Found The Bottom and Ready To Move Up? Find Out Here
Skullcandy Inc (NASDAQ:SKUL) percentage change surged 7.35% to close at $6.28 with the total traded volume of 1,806,524 shares, along with average volume of 329,861.00 shares. The 52 week range of the stock remained $4.80 - $14.58, while its day lowest price was $5.85. The share price hit the day highest price of $6.39. Skullcandy Inc. designs, markets, and distributes performance audio and gaming headphones, and other accessory related products under the Skullcandy, Astro Gaming, and 2XL by Skullcandy brands in the United States and internationally.
For How Long SKUL’s Gloss will Attract Investors? Find out via this report
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) traded on volume of 1,794,387 shares in the last session against average volume of 2.86 million shares. The company started its trading session with the price of $2.92 and closed at $2.86. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders.
How Should Investors Trade CPRX Now? Don’t Miss out a Special Trend Analysis
Geron Corporation (NASDAQ:GERN) started its last trading session with the price of $2.68 and closed at $2.47 by scoring -6.79%. The stock traded with total volume of 1,801,769 shares, while the average trading volume remained 1.18 million shares. The beta value of this stock stands at 0.84. Day range for the stock was $2.46 - $2.68. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Will GERN Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)